William Bains
William is an academic and entrepreneur. After an academic career in UK and the USA, he joined PA Consulting Group in 1988, and Merlin Ventures in 1996. In 1999 William founded Amedis Pharmaceuticals Ltd, (which was later acquired by Paradigm Therapeutics).
He has founded four other biotech companies, has helped create over 10 others, helping to raise over £60M in early stage funding for UK biotech start-ups, as well as sitting on the Advisory Boards of the SULIS Fund, Iceni Fund and Bath Ventures. His latest start-up, Five Alarm Bio Ltd., is developing therapeutics that address the chemical nature of aging.
William continues to be engaged in basic research at MIT, where he is a Research Affiliate applying computational chemistry methods to the search for life on other worlds.
He has founded four other biotech companies, has helped create over 10 others, helping to raise over £60M in early stage funding for UK biotech start-ups, as well as sitting on the Advisory Boards of the SULIS Fund, Iceni Fund and Bath Ventures. His latest start-up, Five Alarm Bio Ltd., is developing therapeutics that address the chemical nature of aging.
William continues to be engaged in basic research at MIT, where he is a Research Affiliate applying computational chemistry methods to the search for life on other worlds.